徳島大学 教育・研究者情報データベース(EDB)

1. (英) Murakami Chiaki

   役割	任意
   貢献度	任意
   学籍番号	推奨

2. (英) Kakuta Nami

   役割	任意
   貢献度	任意
   学籍番号	推奨

3. (英) Satomi Shiho

   役割	任意
   貢献度	任意
   学籍番号	推奨

4. (英) Nakamura Ryuji

   役割	任意
   貢献度	任意
   学籍番号	推奨

5. (英) Miyoshi Hirotsugu

   役割	任意
   貢献度	任意
   学籍番号	推奨

6. (英) Morio Atsushi

   役割	任意
   貢献度	任意
   学籍番号	推奨

7. (英) Saeki Noboru

   役割	任意
   貢献度	任意
   学籍番号	推奨

8. (英) Kato Takahiro

   役割	任意
   貢献度	任意
   学籍番号	推奨

9. (英) Ohshita Naohiro

   役割	任意
   貢献度	任意
   学籍番号	推奨

10. 田中 克哉([徳島大学.大学院医歯薬学研究部.医学域.医科学部門.外科系.麻酔・疼痛治療医学]/[徳島大学.病院.診療科.脳·神経·精神科])

    役割	任意
    貢献度	任意
    学籍番号	推奨

11. (英) Tsutsumi M. Yasuo

    役割	任意
    貢献度	任意
    学籍番号	推奨

(英) [Neurokinin-1 receptor antagonists for postoperative nausea and vomiting: a systematic review and meta-analysis].

(英) Postoperative Nausea and Vomiting (PONV) is a common complication of general anesthesia. Several kinds of antiemetics, including 5-Hydroxytryptamine3 (5-HT3) receptor antagonists and Neurokinin-1 (NK-1) receptor antagonists, have been used to treat PONV. To compare the antiemetic effect of NK-1 receptor antagonists, including fosaprepitant. Online databases (PubMed, MEDLINE, Scopus, The Cochrane Library databases) were used. Randomized Controlled Trials (RCTs) performed in patients over 18 years with ASA-PS of I-III, aimed to assess the efficacy of antiemetics including NK-1 receptor antagonists and 5-HT3 receptor antagonists, and compared the incidence of PONV were included. All statistical assessments were conducted by a random effect approach and odds ratios and 95% Confidence Intervals were calculated. Aprepitant 40mg and 80mg significantly reduced the incidence of vomiting 0-24hours postoperatively (Odds Ratio [OR = 0.40]; 95% Confidence Interval [95% CI 0.30-0.54]; p < 0.001, and OR = 0.32; 95% CI 0.19-0.56; p < 0.001). Fosaprepitant could also reduce the incidence of vomiting significantly both 0-24h and 0-48hours postoperatively (OR = 0.07; 95% CI 0.02-0.24; p < 0.001 and OR = 0.07; 95% CI 0.02-0.23; p < 0.001). Risk factors for PONV are not considered, RCTs using multiple antiemetics are included, RCTs for fosaprepitant is small, and some bias may be present. Aprepitant and fosaprepitant can be effective prophylactic antiemetics for postoperative vomiting. However, more studies are required for higher-quality meta-analyses. CRD42019120188.

1. (英) Article.ELocationID: S0034-7094(20)30352-4

2. (英) Article.ELocationID: 10.1016/j.bjan.2020.04.005

3. (英) Article.PublicationTypeList.PublicationType: English Abstract

4. (英) Article.PublicationTypeList.PublicationType: Journal Article

5. (英) Article.PublicationTypeList.PublicationType: Review

6. (英) Article.VernacularTitle: Antagonistas do receptor da neurocinina 1 no tratamento de n usea e v mito no p sperat rio: Revis o sistem tica e metan lise.

7. (英) KeywordList.Keyword: Antagonistas do receptor NK 1

8. (英) KeywordList.Keyword: NK 1 receptor antagonists

9. (英) KeywordList.Keyword: N usea e v mito no p sperat rio

10. (英) KeywordList.Keyword: Postoperative nausea and vomiting

11. (英) KeywordList.Keyword: Profilaxia

12. (英) KeywordList.Keyword: Prophylaxis

13. (英) KeywordList.Keyword: Tratamento

14. (英) KeywordList.Keyword: Treatment